LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 32 of 497
Next
>>
>
776 to 800 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Buparlisib	0.37	uM	LJP5	2	H04	72	hr	1097	1873	3769	0.4969	0.2903
BT-20	Buparlisib	0.37	uM	LJP5	3	H04	72	hr	1097	2100	3769	0.5571	0.3752
BT-20	BX-912	0.37	uM	LJP5	1	L22	72	hr	1097	3384	3769	0.8977	0.8557
BT-20	BX-912	0.37	uM	LJP5	2	L22	72	hr	1097	3509	3769	0.9309	0.9025
BT-20	BX-912	0.37	uM	LJP5	3	L22	72	hr	1097	3956	3769	1.0495	1.0698
BT-20	Canertinib	0.37	uM	LJP6	1	H10	72	hr	1097	3102	3769	0.8229	0.7502
BT-20	Canertinib	0.37	uM	LJP6	2	H10	72	hr	1097	3152	3769	0.8362	0.7689
BT-20	Canertinib	0.37	uM	LJP6	3	H10	72	hr	1097	3046	3769	0.8081	0.7292
BT-20	Celastrol	0.37	uM	LJP6	1	G10	72	hr	1097	3324	3769	0.8818	0.8333
BT-20	Celastrol	0.37	uM	LJP6	2	G10	72	hr	1097	3080	3769	0.8171	0.7420
BT-20	Celastrol	0.37	uM	LJP6	3	G10	72	hr	1097	3303	3769	0.8762	0.8254
BT-20	CGP60474	0.37	uM	LJP5	1	F04	72	hr	1097	674	3769	0.1788	-0.1584
BT-20	CGP60474	0.37	uM	LJP5	2	F04	72	hr	1097	663	3769	0.1759	-0.1625
BT-20	CGP60474	0.37	uM	LJP5	3	F04	72	hr	1097	812	3769	0.2154	-0.1068
BT-20	CGP60474	0.37	uM	LJP6	1	G04	72	hr	1097	658	3769	0.1746	-0.1644
BT-20	CGP60474	0.37	uM	LJP6	2	G04	72	hr	1097	637	3769	0.1690	-0.1722
BT-20	CGP60474	0.37	uM	LJP6	3	G04	72	hr	1097	635	3769	0.1685	-0.1730
BT-20	CHIR-99021	0.37	uM	LJP6	1	P16	72	hr	1097	3152	3769	0.8362	0.7689
BT-20	CHIR-99021	0.37	uM	LJP6	2	P16	72	hr	1097	3073	3769	0.8152	0.7394
BT-20	CHIR-99021	0.37	uM	LJP6	3	P16	72	hr	1097	3510	3769	0.9312	0.9029
BT-20	CP724714	0.37	uM	LJP5	1	A10	72	hr	1097	3661	3769	0.9712	0.9594
BT-20	CP724714	0.37	uM	LJP5	2	A10	72	hr	1097	3688	3769	0.9784	0.9695
BT-20	CP724714	0.37	uM	LJP5	3	A10	72	hr	1097	3581	3769	0.9500	0.9295
BT-20	CP466722	0.37	uM	LJP5	1	I10	72	hr	1097	3966	3769	1.0521	1.0735
BT-20	CP466722	0.37	uM	LJP5	2	I10	72	hr	1097	3554	3769	0.9428	0.9193

|<
<<
Previous
Page 32 of 497
Next
>>
>
776 to 800 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)